Who owns Revolution Medicines?
- Ticker: RVMD
- CUSIP Number: 76155x100
Tip: Access positions for across all investors
Analyze quarterly positions in Revolution Medicines with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Revolution Medicines stock
Who bought or sold Revolution Medicines this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Vanguard Group | 17M | $1.3B | 7% | Dec 2025 |
|
| Farallon Capital Management | 15M | $1.2B | 0% | Dec 2025 |
|
| BlackRock | 11M | $1.1B | 26% | Mar 2026 |
|
| Henderson Group | 9.8M | $950M | -14% | Mar 2026 |
|
| Baker Bros. Advisors | 9.6M | $929M | 1% | Mar 2026 |
|
| FMR | 8.6M | $684M | -9% | Dec 2025 |
|
| Vanguard Capital Management | 8.4M | $813M | 100% | Mar 2026 |
|
| Nextech Invest | 7.6M | $739M | 0% | Mar 2026 |
|
| Vanguard Portfolio Management | 7.5M | $730M | 100% | Mar 2026 |
|
| Wellington Management Company | 7.0M | $557M | -29% | Dec 2025 |
|
| Paradigm Biocapital Advisors | 6.7M | $647M | 0% | Mar 2026 |
|
| Bellevue Group | 5.0M | $399M | -10% | Dec 2025 |
|
| UBS Group | 4.4M | $427M | 42% | Mar 2026 |
|
| State Street Corporation | 4.1M | $327M | -22% | Dec 2025 |
|
| Geode Capital Management | 3.3M | $324M | 6% | Mar 2026 |
|
| Alphabet | 3.3M | $320M | -2% | Mar 2026 |
|
| BVF | 2.9M | $278M | -15% | Mar 2026 |
|
| General Atlantic | 2.8M | $224M | 14% | Dec 2025 |
|
| Casdin Capital | 2.6M | $251M | 0% | Mar 2026 |
|
| Woodline Partners | 2.5M | $244M | 0% | Mar 2026 |
|
| Holocene Advisors | 2.5M | $240M | 29% | Mar 2026 |
|
| Vestal Point Capital | 2.4M | $231M | 705% | Mar 2026 |
|
| Deerfield Management Company | 2.3M | $223M | -21% | Mar 2026 |
|
| Darwin Global Management | 2.2M | $205M | 100% | Mar 2026 |
|
| Adage Capital Partners GP | 2.2M | $176M | 197% | Dec 2025 |
|
| T. Rowe Price Investment Management | 2.2M | $175M | -54% | Dec 2025 |
|
| Goldman Sachs Group | 2.2M | $213M | -14% | Mar 2026 |
|
| venBio Select Advisor | 2.2M | $173M | 100% | Dec 2025 |
|
| Polar Capital Holdings | 2.0M | $160M | 321% | Dec 2025 |
|
| Logos Global Management | 2.0M | $195M | -33% | Mar 2026 |
|
| Alyeska Investment Group | 1.9M | $183M | 689% | Mar 2026 |
|
| Abu Dhabi Investment Council Co P.J.S.C | 1.7M | $19M | 100% | Mar 2026 |
|
| Charles Schwab Investment Management | 1.7M | $134M | 3% | Dec 2025 |
|
| Ameriprise Financial | 1.6M | $154M | -23% | Mar 2026 |
|
| Two Sigma Investments | 1.6M | $152M | 270% | Mar 2026 |
|
| Westfield Capital Management Company | 1.6M | $151M | -45% | Mar 2026 |
|
| Siren | 1.3M | $106M | 28% | Dec 2025 |
|
| Caligan Partners | 1.3M | $102M | 21% | Dec 2025 |
|
| Susquehanna International | 1.2M | $98M | 12% | Dec 2025 |
|
| Rock Springs Capital Management | 1.2M | $118M | -9% | Mar 2026 |
|
| Integral Health Asset Management | 1.2M | $96M | 200% | Dec 2025 |
|
| Franklin Resources | 1.1M | $110M | 7% | Mar 2026 |
|
| Vanguard Fiduciary Trust | 1.1M | $110M | 100% | Mar 2026 |
|
| D. E. Shaw & Co | 1.1M | $105M | -33% | Mar 2026 |
|
| Citadel Advisors | 1.0M | $98M | -30% | Mar 2026 |
|
| Hood River Capital Management | 946k | $75M | 2% | Dec 2025 |
|
| AH Capital Management | 921k | $90M | 0% | Mar 2026 |
|
| Boothbay Fund Management | 851k | $83M | 141% | Mar 2026 |
|
| Northern Trust | 850k | $68M | -1% | Dec 2025 |
|
| Dimensional Fund Advisors | 845k | $82M | -27% | Mar 2026 |
|
| AIHC Capital Management | 829k | $81M | 100% | Mar 2026 |
|
| MIC Capital Management UK | 796k | $77M | 56% | Mar 2026 |
|
| Caption Management | 736k | $59M | -17% | Dec 2025 |
|
| Morgan Stanley | 706k | $69M | 8% | Mar 2026 |
|
| Frazier Life Sciences Management | 676k | $66M | -15% | Mar 2026 |
|
| First Turn Management | 638k | $51M | -1% | Dec 2025 |
|
| Bank of New York Mellon | 635k | $62M | 17% | Mar 2026 |
|
| Worldquant Millennium Quantitative Strategies | 622k | $61M | 562% | Mar 2026 |
|
| HealthInvest Partners AB | 617k | $9.1M | 584% | Mar 2026 |
|
| Bank of America Corporation | 614k | $60M | 100% | Mar 2026 |
|
| DAFNA Capital Management | 581k | $57M | -4% | Mar 2026 |
|
| Candriam Luxembourg S.C.A. | 581k | $57M | -44% | Mar 2026 |
|
| TCG Crossover Management | 577k | $56M | 32% | Mar 2026 |
|
| Pictet Asset Management Holding SA | 558k | $54M | -51% | Mar 2026 |
|
| Lunate Capital | 549k | $53M | -75% | Mar 2026 |
|
| MPM Oncology Impact Management | 507k | $49M | 0% | Mar 2026 |
|
| Ubs Global Asset Management Americas | 501k | $49M | 43% | Mar 2026 |
|
| Nationale-Nederlanden Powszechne Towarzystwo Emerytalne | 479k | $47M | 100% | Mar 2026 |
|
| American Century Companies | 467k | $37M | 4% | Dec 2025 |
|
| Deutsche Bank Aktiengesellschaft | 466k | $45M | 1346% | Mar 2026 |
|
| Frontier Capital Management | 431k | $34M | 251% | Dec 2025 |
|
| Swiss National Bank | 425k | $41M | 54% | Mar 2026 |
|
| Bnp Paribas Arbitrage, Snc | 422k | $41M | -32% | Mar 2026 |
|
| Boxer Capital Management | 400k | $32M | 0% | Dec 2025 |
|
| Invesco | 393k | $38M | 7% | Mar 2026 |
|
| Marshall Wace | 386k | $31M | 140% | Dec 2025 |
|
| Stempoint Capital | 382k | $2.0M | 515% | Mar 2026 |
|
| Eventide Asset Management | 378k | $30M | -36% | Dec 2025 |
|
| Millennium Management | 377k | $37M | -55% | Mar 2026 |
|
| Samlyn Capital | 372k | $36M | 100% | Mar 2026 |
|
| Royal Bank of Canada | 372k | $36M | 93% | Mar 2026 |
|
| Jane Street | 370k | $36M | -70% | Mar 2026 |
|
| Voloridge Investment Management | 368k | $36M | 14% | Mar 2026 |
|
| Partners HealthCare System | 344k | $34M | 0% | Mar 2026 |
|
| Legal & General Group | 341k | $33M | 122% | Mar 2026 |
|
| Nuveen | 341k | $33M | -16% | Mar 2026 |
|
| LMR Partners | 340k | $33M | 100% | Mar 2026 |
|
| TD Asset Management | 318k | $31M | -14% | Mar 2026 |
|
| Nicholas Investments Partners | 318k | $25M | 19% | Dec 2025 |
|
| Duquesne Family Office | 316k | $31M | 100% | Mar 2026 |
|
| Jennison Associates | 307k | $30M | 1% | Mar 2026 |
|
| CalPERS | 282k | $27M | -3% | Mar 2026 |
|
| Man Group | 275k | $27M | 182% | Mar 2026 |
|
| Sumitomo Mitsui Trust Holdings | 271k | $26M | 4829% | Mar 2026 |
|
| Melqart Asset Management | 270k | $26M | 100% | Mar 2026 |
|
| Checkpoint Capital | 263k | $26M | -29% | Mar 2026 |
|
| Perceptive Advisors | 259k | $25M | 100% | Mar 2026 |
|
| Ikarian Capital | 258k | $25M | 11% | Mar 2026 |
|
| Trails Edge Capital Partners | 245k | $24M | 100% | Mar 2026 |
|
| Raymond James Financial | 244k | $19M | -12% | Dec 2025 |
|
| Ensign Peak Advisors | 228k | $22M | -3% | Mar 2026 |
|
| Marsico Capital Management | 220k | $21M | 0% | Mar 2026 |
|
| Fisher Investments | 216k | $21M | -10% | Mar 2026 |
|
| Kynam Capital Management | 208k | $20M | 100% | Mar 2026 |
|
| Verition Fund Management | 189k | $15M | 40% | Dec 2025 |
|
| Baillie Gifford & Co | 187k | $18M | -4% | Mar 2026 |
|
| Rhumbline Advisers | 180k | $18M | 12% | Mar 2026 |
|
| California State Teachers Retirement System | 165k | $16M | 22% | Mar 2026 |
|
| Mitsubishi UFJ Asset Management | 165k | $16M | 424% | Mar 2026 |
|
| Birnam Oak Advisors | 159k | $16M | 100% | Mar 2026 |
|
| Squarepoint Ops | 155k | $15M | 556% | Mar 2026 |
|
| Partner Fund Management | 152k | $12M | -54% | Dec 2025 |
|
| Florida State Board of Administration | 145k | $14M | 11% | Mar 2026 |
|
| Manufacturers Life Insurance Company | 141k | $14M | -18% | Mar 2026 |
|
| Victory Capital Management | 139k | $11M | -45% | Dec 2025 |
|
| Amundi | 139k | $14M | 590% | Mar 2026 |
|
| Toroso Investments | 137k | $13M | 100% | Mar 2026 |
|
| Barclays | 136k | $11M | -53% | Dec 2025 |
|
| Lord, Abbett & Co | 134k | $13M | -66% | Mar 2026 |
|
| ADAR1 Capital Management | 134k | $13M | -8% | Mar 2026 |
|
| Gotham Asset Management | 126k | $12M | 11% | Mar 2026 |
|
| Artia Global Partners | 125k | $12M | 20% | Mar 2026 |
|
| New York State Common Retirement Fund | 125k | $12M | -4% | Mar 2026 |
|
| Balyasny Asset Management | 124k | $12M | -80% | Mar 2026 |
|
| HighVista Strategies | 120k | $9.6M | -31% | Dec 2025 |
|
| Eagle Health Investments | 120k | $12M | 3% | Mar 2026 |
|
| AQR Capital Management | 117k | $11M | -8% | Mar 2026 |
|
| Standard Life Aberdeen | 115k | $11M | 1% | Mar 2026 |
|
| WCM Investment Management | 105k | $9.7M | -10% | Mar 2026 |
|
| a16z Perennial Management | 104k | $10M | -43% | Mar 2026 |
|
| Bnp Paribas Investment Partners | 104k | $8.2M | 8015% | Dec 2025 |
|
| ING Groep | 103k | $10M | 100% | Mar 2026 |
|
| Empyrean Capital Partners | 102k | $10M | 100% | Mar 2026 |
|
| Opaleye Management | 100k | $9.7M | 0% | Mar 2026 |
|
| Kite Lake Capital Management | 100k | $9.7M | 100% | Mar 2026 |
|
| Affinity Asset Advisors | 100k | $8.0M | 0% | Dec 2025 |
|
| Granahan Investment Management | 99k | $7.9M | -16% | Dec 2025 |
|
| Russell Investments | 99k | $9.6M | 0% | Mar 2026 |
|
| Tema Etfs | 98k | $9.5M | -2% | Mar 2026 |
|
| State of Wisconsin Investment Board | 98k | $7.8M | -12% | Dec 2025 |
|
| Decheng Capital | 94k | $9.1M | -53% | Mar 2026 |
|
| Connor, Clark & Lunn Investment Management | 92k | $8.9M | 100% | Mar 2026 |
|
| Citigroup | 90k | $8.7M | 100% | Mar 2026 |
|
| Canada Pension Plan Investment Board | 89k | $8.7M | -18% | Mar 2026 |
|
| Tudor Investment Corporation | 88k | $8.5M | -5% | Mar 2026 |
|
| Braidwell | 85k | $8.3M | 100% | Mar 2026 |
|
| Seven Fleet Capital Management | 81k | $7.9M | 23% | Mar 2026 |
|
| Vanguard Asset Management | 81k | $7.8M | 100% | Mar 2026 |
|
| Vanguard Global Advisers | 79k | $7.6M | 100% | Mar 2026 |
|
| Algert Coldiron Investors | 75k | $7.3M | -34% | Mar 2026 |
|
| M&G | 75k | $7.2M | -16% | Mar 2026 |
|
| Rafferty Asset Management | 75k | $5.9M | -58% | Dec 2025 |
|
| Catalyst Funds Management Pty | 66k | $6.4M | -70% | Mar 2026 |
|
| Mitsubishi UFJ Securities International | 49k | $4.8M | -60% | Mar 2026 |
|
| Bessemer | 48k | $4.7M | -59% | Mar 2026 |
|
| Brian McDonald | 23k | $1.9M | -95% | Dec 2025 |
|
| Bank of Nova Scotia | 10k | $1.0M | -92% | Mar 2026 |
|
| Zweig-DiMenna Associates | 8.3k | $806k | -92% | Mar 2026 |
|
| Point72 Asset Management | 2.6k | $253k | -99% | Mar 2026 |
|
| Leucadia National Corporation | 2.5k | $242k | -100% | Mar 2026 |
|
Who sold out of Revolution Medicines?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Jpmorgan Chase & Co | Sep 2025 | 2.5M | $117M |
| Norges Bank Investment Management | Dec 2025 | 2.5M | $196M |
| Two Sigma Advisers | Dec 2025 | 288k | $23M |
| Renaissance Technologies | Sep 2025 | 253k | $12M |
| Caisse de depot et placement du Quebec | Sep 2025 | 108k | $5.1M |
| NEOS Investment Management | Dec 2025 | 102k | $8.1M |